CRIMINI, EDOARDO

CRIMINI, EDOARDO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 21 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population 2022 Mazzarella, LGiugliano, FNicolo', ECrimini, EUliano, JCorti, CRepetto, MAntonarelli, GAscione, LVivanet, GCriscitiello, CCurigliano, G + Article (author) -
Adjuvant treatment of early male breast cancer 2020 Corti C.Crimini E.Criscitiello C.Trapani D.Curigliano G. Article (author) -
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents 2023 Tarantino, PaoloAntonarelli, GabrieleBoscolo Bielo, LucaCrimini, EdoardoGiugliano, FedericaZagami, PaolaCorti, ChiaraTrapani, DarioCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 2022 Tarantino, PaoloAntonarelli, GabrieleBoscolo Bielo, LucaMarra, AntonioCrimini, EdoardoGiugliano, FedericaZagami, PaolaCorti, ChiaraTrapani, DarioMorganti, StefaniaCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis 2021 Trapani, DCorti, CCrimini, EBellerba, FCriscitiello, CCurigliano, G + Article (author) -
Characterization of low HER2 expressions in de-novo metastatic breast cancer 2021 Tarantino, PZagami, PGiugliano, FCrimini, ECorti, CUliano, JMorganti, SCriscitiello, CCurigliano, G + Article (author) -
Clinical development and current role of margetuximab for the treatment of breast cancer 2021 Uliano J.Morganti S.Giugliano F.Crimini E.Curigliano G. + Article (author) -
COVID-19 related risk in patients enrolled in early-phase clinical trials 2021 Morganti, SCorti, CVivanet, GCrimini, EAntonarelli, GCurigliano, G + Article (author) -
First line treatment of BRAF mutated advanced melanoma: Does one size fit all? 2021 Giugliano, FedericaCrimini, EdoardoZagami, PaolaUliano, JacopoCorti, ChiaraTrapani, DarioCurigliano, Giuseppe + Article (author) -
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer 2022 Venetis K.Crimini E.Sajjadi E.Corti C.Guerini-Rocco E.Viale G.Curigliano G.Criscitiello C.Fusco N. Article (author) -
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy 2021 Giugliano, FCrimini, EUliano, JCorti, CRepetto, MAntonarelli, GVivanet, GCriscitiello, CCurigliano, G + Article (author) -
Margetuximab for the treatment of HER2-positive metastatic breast cancer 2021 Morganti S.Uliano J.Giugliano F.Crimini E.Curigliano G. + Article (author) -
Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go? 2023 Trapani, DarioCrimini, EdoardoCurigliano, Giuseppe + Book Part (author) -
Precision medicine in breast cancer : From clinical trials to clinical practice 2021 Crimini, EdoardoRepetto, MatteoCurigliano, Giuseppe + Article (author) -
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation? 2022 Morganti S.Crimini E.Zagami P.Curigliano G. + Article (author) -
Safety of covid-19 mrna vaccines in patients with cancer enrolled in early-phase clinical trials 2021 Trillo Aliaga P.Trapani D.Crimini E.Antonarelli G.Vivanet G.Morganti S.Corti C.Criscitiello C.Curigliano G. + Article (author) -
SARS-CoV-2 vaccines for cancer patients: a call to action 2021 Corti, ChiaraCrimini, EdoardoPravettoni, GabriellaCurigliano, Giuseppe + Article (author) -
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions 2021 Repetto M.Crimini E.Giugliano F.Morganti S.Curigliano G. + Article (author) -
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running? 2023 Trillo Aliaga, PamelaCorti, ChiaraCrimini, Edoardo + Article (author) -
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 2021 Crimini E.Corti C.Repetto M.Giugliano F.Antonarelli G.Zagami P.Morganti S.Uliano J.Curigliano G. + Article (author) -